Orthocell Limited (ASX:OCC)

Orthocell Statistics

Total Valuation

Orthocell has a market cap or net worth of AUD 240.11 million. The enterprise value is 196.25 million.

Market Cap	240.11M
Enterprise Value	196.25M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Orthocell has 271.31 million shares outstanding. The number of shares has increased by 14.29% in one year.

Current Share Class	271.31M
Shares Outstanding	271.31M
Shares Change (YoY)	+14.29%
Shares Change (QoQ)	+7.69%
Owned by Insiders (%)	14.77%
Owned by Institutions (%)	3.31%
Float	228.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.73
PB Ratio	5.83
P/TBV Ratio	5.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.72
EV / Sales	21.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.07

Financial Position

The company has a current ratio of 9.17, with a Debt / Equity ratio of 0.01.

Current Ratio	9.17
Quick Ratio	8.84
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.06% and return on invested capital (ROIC) is -33.78%.

Return on Equity (ROE)	-41.06%
Return on Assets (ROA)	-20.97%
Return on Invested Capital (ROIC)	-33.78%
Return on Capital Employed (ROCE)	-30.91%
Weighted Average Cost of Capital (WACC)	2.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.19
Inventory Turnover	2.56

Taxes

Income Tax	-3.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.00% in the last 52 weeks. The beta is -0.32, so Orthocell's price volatility has been lower than the market average.

Beta (5Y)	-0.32
52-Week Price Change	-25.00%
50-Day Moving Average	0.98
200-Day Moving Average	1.15
Relative Strength Index (RSI)	38.87
Average Volume (20 Days)	275,104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orthocell had revenue of AUD 9.33 million and -12.48 million in losses. Loss per share was -0.05.

Revenue	9.33M
Gross Profit	5.95M
Operating Income	-16.75M
Pretax Income	-15.67M
Net Income	-12.48M
EBITDA	-16.45M
EBIT	-16.75M
Loss Per Share	-0.05

Balance Sheet

The company has 44.37 million in cash and 510,603 in debt, with a net cash position of 43.86 million or 0.16 per share.

Cash & Cash Equivalents	44.37M
Total Debt	510,603
Net Cash	43.86M
Net Cash Per Share	0.16
Equity (Book Value)	41.16M
Book Value Per Share	0.15
Working Capital	45.83M

Cash Flow

In the last 12 months, operating cash flow was -12.05 million and capital expenditures -159,092, giving a free cash flow of -12.21 million.

Operating Cash Flow	-12.05M
Capital Expenditures	-159,092
Free Cash Flow	-12.21M
FCF Per Share	-0.05

Margins

Gross margin is 63.77%, with operating and profit margins of -179.48% and -133.78%.

Gross Margin	63.77%
Operating Margin	-179.48%
Pretax Margin	-167.91%
Profit Margin	-133.78%
EBITDA Margin	-176.29%
EBIT Margin	-179.48%
FCF Margin	n/a

Dividends & Yields

Orthocell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.29%
Shareholder Yield	-14.29%
Earnings Yield	-5.20%
FCF Yield	-5.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Orthocell has an Altman Z-Score of 8.52 and a Piotroski F-Score of 3.

Altman Z-Score	8.52
Piotroski F-Score	3